Shining a Light on How Big Pharma is Rapidly Increasing Prices on Oncology Drugs A new blog from America’s Health Insurance Plans (AHIP) highlights how Big Pharma’s pricing practices on oncology medications have created an affordability crisis for many cancer patients. The blog cites a recent analysis in the Journal of the American Medical Association […]
What Comes Next After Major Step Forward on Drug Pricing Real Clear Health Lauren Aronson September 19, 2022 With the passage of the Inflation Reduction Act of 2022, Congress and the Biden administration took a major step toward holding Big Pharma accountable and delivered a significant victory for millions of Americans facing out-of-control drug prices. […]
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will Cause U.S. Patients To Spend $167 Billion on Just Three Branded Drugs Over Seven Years A new report from the Initiative for Medicines, Access, & Knowledge (I-MAK) examines the cost of Big Pharma’s abuse of the patent system in the U.S. and the negative impact of delayed competition […]
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance Programs Boost Sales of High-Priced Products and “Violate the Spirit of Medicare’s Anti-Kickback Statute” A new study in Health Affairs demonstrates how Big Pharma companies skirt anti-kickback protections in federal law by using so-called patient assistance charities to undermine competition in the market and pad their […]
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually Wrong” and Highlights the Need for Additional, Market-Based Solutions to Increase Competition In an interview on C-SPAN’s Washington Journal program this week, Avik Roy, president of the Foundation for Research on Equal Opportunity (FREOPP), debunked Big Pharma’s bogus innovation rhetoric and highlighted the importance of market-based solutions […]
Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big Pharma’s Egregious Practices, a Burden for Patients and the Health Care System A new report this week from the Health Care Cost Institute finds spending on prescription drugs in the U.S. continues to rise – and remains a burden for patients and the health care system – […]
Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with Increasingly Staggering Price Tags In case you missed it, a new Reuters analysis found Big Pharma is on pace to break records with out-of-control launch prices on new prescription drugs coming to market this year, further underscoring how brand name drug companies set egregious prices on […]
Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower Drug Prices Will Crimp Innovation On Monday, Avik Roy, president of the Foundation for Research on Equal Opportunity (FREOPP), and Gregg Girvan, a resident fellow at FREOPP, published an op-ed in The Washington Post debunking Big Pharma’s false and hyperbolic claims that passing the drug […]
Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Earlier This Year This week, brand name drug giants AbbVie, AstraZeneca and Amgen all announced earnings and profits for the second quarter of 2022 that topped Wall Street analysts’ expectations. The Big Pharma giants reported blockbuster earnings and revenue estimates after hiking drug prices […]
Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High by Re-Upping False Claims, Blame Game and Discredited Innovation Rhetoric On Thursday, the Pharmaceutical Research and Manufacturers of America (PhRMA) sent a letter from the organization’s board of directors in a last-minute bid to intimidate lawmakers into voting against drug pricing solutions included in the […]